Innovation and acceleration in clinical drug development:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | Undetermined |
| Veröffentlicht: |
New York
Raven Pr.
1987
|
| Schriftenreihe: | MEDAC: MEDAC
1986 |
| Schlagworte: | |
| Beschreibung: | XI, 170 S. |
| ISBN: | 0881673463 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV000782897 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 880802s1987 |||| 10||| und d | ||
| 020 | |a 0881673463 |9 0-88167-346-3 | ||
| 035 | |a (OCoLC)230917643 | ||
| 035 | |a (DE-599)BVBBV000782897 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | |a und | ||
| 049 | |a DE-12 | ||
| 245 | 1 | 0 | |a Innovation and acceleration in clinical drug development |c Merck Sharp & Dohme Internat. Med. Advisory Council, Siena, Italy, June 9 - 10, 1986. Ed. Louis Lasagna ... |
| 264 | 1 | |a New York |b Raven Pr. |c 1987 | |
| 300 | |a XI, 170 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a MEDAC: MEDAC |v 1986 | |
| 650 | 0 | 7 | |a Klinische Prüfung |0 (DE-588)4031192-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1986 |z Siena |2 gnd-content | |
| 689 | 0 | 0 | |a Klinische Prüfung |0 (DE-588)4031192-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Lasagna, Louis |e Sonstige |4 oth | |
| 830 | 0 | |a MEDAC: MEDAC |v 1986 |w (DE-604)BV026162137 |9 1986 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000490304 | ||
Datensatz im Suchindex
| _version_ | 1804115234360655872 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV000782897 |
| ctrlnum | (OCoLC)230917643 (DE-599)BVBBV000782897 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01123nam a2200325 cb4500</leader><controlfield tag="001">BV000782897</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">880802s1987 |||| 10||| und d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0881673463</subfield><subfield code="9">0-88167-346-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)230917643</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000782897</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Innovation and acceleration in clinical drug development</subfield><subfield code="c">Merck Sharp & Dohme Internat. Med. Advisory Council, Siena, Italy, June 9 - 10, 1986. Ed. Louis Lasagna ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Raven Pr.</subfield><subfield code="c">1987</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 170 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">MEDAC: MEDAC</subfield><subfield code="v">1986</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Klinische Prüfung</subfield><subfield code="0">(DE-588)4031192-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1986</subfield><subfield code="z">Siena</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Klinische Prüfung</subfield><subfield code="0">(DE-588)4031192-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lasagna, Louis</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">MEDAC: MEDAC</subfield><subfield code="v">1986</subfield><subfield code="w">(DE-604)BV026162137</subfield><subfield code="9">1986</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000490304</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1986 Siena gnd-content |
| genre_facet | Konferenzschrift 1986 Siena |
| id | DE-604.BV000782897 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T15:19:22Z |
| institution | BVB |
| isbn | 0881673463 |
| language | Undetermined |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000490304 |
| oclc_num | 230917643 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | XI, 170 S. |
| publishDate | 1987 |
| publishDateSearch | 1987 |
| publishDateSort | 1987 |
| publisher | Raven Pr. |
| record_format | marc |
| series | MEDAC: MEDAC |
| series2 | MEDAC: MEDAC |
| spelling | Innovation and acceleration in clinical drug development Merck Sharp & Dohme Internat. Med. Advisory Council, Siena, Italy, June 9 - 10, 1986. Ed. Louis Lasagna ... New York Raven Pr. 1987 XI, 170 S. txt rdacontent n rdamedia nc rdacarrier MEDAC: MEDAC 1986 Klinische Prüfung (DE-588)4031192-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1986 Siena gnd-content Klinische Prüfung (DE-588)4031192-2 s DE-604 Lasagna, Louis Sonstige oth MEDAC: MEDAC 1986 (DE-604)BV026162137 1986 |
| spellingShingle | Innovation and acceleration in clinical drug development MEDAC: MEDAC Klinische Prüfung (DE-588)4031192-2 gnd |
| subject_GND | (DE-588)4031192-2 (DE-588)1071861417 |
| title | Innovation and acceleration in clinical drug development |
| title_auth | Innovation and acceleration in clinical drug development |
| title_exact_search | Innovation and acceleration in clinical drug development |
| title_full | Innovation and acceleration in clinical drug development Merck Sharp & Dohme Internat. Med. Advisory Council, Siena, Italy, June 9 - 10, 1986. Ed. Louis Lasagna ... |
| title_fullStr | Innovation and acceleration in clinical drug development Merck Sharp & Dohme Internat. Med. Advisory Council, Siena, Italy, June 9 - 10, 1986. Ed. Louis Lasagna ... |
| title_full_unstemmed | Innovation and acceleration in clinical drug development Merck Sharp & Dohme Internat. Med. Advisory Council, Siena, Italy, June 9 - 10, 1986. Ed. Louis Lasagna ... |
| title_short | Innovation and acceleration in clinical drug development |
| title_sort | innovation and acceleration in clinical drug development |
| topic | Klinische Prüfung (DE-588)4031192-2 gnd |
| topic_facet | Klinische Prüfung Konferenzschrift 1986 Siena |
| volume_link | (DE-604)BV026162137 |
| work_keys_str_mv | AT lasagnalouis innovationandaccelerationinclinicaldrugdevelopment |